Companies

Hvivo signs €7.3m contract to test common cold treatment

Study will evaluate the effect of the antiviral candidate on viral load, safety and tolerability against HRV infection in healthy volunteers

Cathal Friel, Hvivo founder and chairman. Picture: Fergal Phillips